Annual Net Income
-$98.43 M
+$10.46 M+9.60%
31 December 2023
Summary:
Foghorn Therapeutics annual net profit is currently -$98.43 million, with the most recent change of +$10.46 million (+9.60%) on 31 December 2023. During the last 3 years, it has fallen by -$29.63 million (-43.06%). FHTX annual net income is now -273.72% below its all-time high of -$26.34 million, reached on 31 December 2018.FHTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$19.12 M
+$3.86 M+16.78%
30 September 2024
Summary:
Foghorn Therapeutics quarterly net profit is currently -$19.12 million, with the most recent change of +$3.86 million (+16.78%) on 30 September 2024. Over the past year, it has dropped by -$4.78 million (-33.30%). FHTX quarterly net income is now -46.06% below its all-time high of -$13.09 million, reached on 30 September 2019.FHTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$91.22 M
-$4.78 M-5.53%
30 September 2024
Summary:
Foghorn Therapeutics TTM net profit is currently -$91.22 million, with the most recent change of -$4.78 million (-5.53%) on 30 September 2024. Over the past year, it has increased by +$11.98 million (+11.61%). FHTX TTM net income is now -596.78% below its all-time high of -$13.09 million, reached on 30 September 2019.FHTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.6% | -33.3% | +11.6% |
| 3 y3 years | -43.1% | +26.7% | +1.8% |
| 5 y5 years | -273.7% | -46.1% | -596.8% |
FHTX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -43.1% | +9.6% | -33.3% | +37.3% | -5.5% | +20.4% |
| 5 y | 5 years | -273.7% | +9.6% | -46.1% | +37.3% | -596.8% | +20.4% |
| alltime | all time | -273.7% | +9.6% | -46.1% | +37.3% | -596.8% | +20.4% |
Foghorn Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$19.12 M(-16.8%) | -$91.22 M(+5.5%) |
| June 2024 | - | -$22.98 M(-8.1%) | -$86.45 M(-7.0%) |
| Mar 2024 | - | -$25.02 M(+3.8%) | -$92.95 M(-5.6%) |
| Dec 2023 | -$98.43 M(-9.6%) | -$24.11 M(+68.0%) | -$98.43 M(-4.6%) |
| Sept 2023 | - | -$14.35 M(-51.4%) | -$103.21 M(-10.0%) |
| June 2023 | - | -$29.49 M(-3.3%) | -$114.63 M(+1.9%) |
| Mar 2023 | - | -$30.49 M(+5.5%) | -$112.46 M(+3.3%) |
| Dec 2022 | -$108.88 M(+7.5%) | -$28.89 M(+12.1%) | -$108.88 M(-0.2%) |
| Sept 2022 | - | -$25.77 M(-5.7%) | -$109.14 M(-0.3%) |
| June 2022 | - | -$27.31 M(+1.5%) | -$109.45 M(+4.0%) |
| Mar 2022 | - | -$26.91 M(-7.6%) | -$105.25 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$101.32 M(+47.3%) | -$29.14 M(+11.7%) | -$101.32 M(+9.0%) |
| Sept 2021 | - | -$26.08 M(+12.8%) | -$92.94 M(+9.1%) |
| June 2021 | - | -$23.11 M(+0.5%) | -$85.22 M(+9.5%) |
| Mar 2021 | - | -$22.99 M(+10.7%) | -$77.83 M(+13.1%) |
| Dec 2020 | -$68.80 M(+34.6%) | -$20.76 M(+13.0%) | -$68.80 M(+8.6%) |
| Sept 2020 | - | -$18.37 M(+16.8%) | -$63.33 M(+9.1%) |
| June 2020 | - | -$15.72 M(+12.7%) | -$58.06 M(+37.1%) |
| Mar 2020 | - | -$13.95 M(-8.8%) | -$42.34 M(+49.2%) |
| Dec 2019 | -$51.13 M(+94.1%) | -$15.29 M(+16.8%) | -$28.38 M(+116.8%) |
| Sept 2019 | - | -$13.09 M | -$13.09 M |
| Dec 2018 | -$26.34 M | - | - |
FAQ
- What is Foghorn Therapeutics annual net profit?
- What is the all time high annual net income for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual net income year-on-year change?
- What is Foghorn Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly net income year-on-year change?
- What is Foghorn Therapeutics TTM net profit?
- What is the all time high TTM net income for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM net income year-on-year change?
What is Foghorn Therapeutics annual net profit?
The current annual net income of FHTX is -$98.43 M
What is the all time high annual net income for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual net profit is -$26.34 M
What is Foghorn Therapeutics annual net income year-on-year change?
Over the past year, FHTX annual net profit has changed by +$10.46 M (+9.60%)
What is Foghorn Therapeutics quarterly net profit?
The current quarterly net income of FHTX is -$19.12 M
What is the all time high quarterly net income for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly net profit is -$13.09 M
What is Foghorn Therapeutics quarterly net income year-on-year change?
Over the past year, FHTX quarterly net profit has changed by -$4.78 M (-33.30%)
What is Foghorn Therapeutics TTM net profit?
The current TTM net income of FHTX is -$91.22 M
What is the all time high TTM net income for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM net profit is -$13.09 M
What is Foghorn Therapeutics TTM net income year-on-year change?
Over the past year, FHTX TTM net profit has changed by +$11.98 M (+11.61%)